Phio Pharmaceuticals Corp reports results for the quarter ended in June - Earnings Summary

Phio Pharmaceuticals

11/08/2022 23:43

* Phio Pharmaceuticals Corp  PHIO.OQ  reported a quarterly
adjusted loss of 19 cents​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 31 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Phio Pharmaceuticals Corp's reported EPS for the quarter
was a
loss of 19 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Phio Pharmaceuticals Corp shares had risen by 12.8% this
quarter and lost 20.8% so far this year.
    * The company reported a quarterly loss of $2.53 million.
    * Wall Street's median 12-month price target for Phio
Pharmaceuticals Corp is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 10:42 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.31          -0.19          Beat
 Mar. 31 2022      -0.30          -0.19          Beat
 Dec. 31 2021      -0.32          -0.27          Beat
 Sep. 30 2021      -0.25          -0.28          Missed